steve harr md cfo hyam levitsky md cso juno therapeutics inc american biopharmaceutical company founded collaboration fred hutchinson cancer research center memorial sloankettering cancer center pediatrics partner seattle childrens research institute company launched initial investment million remit develop pipeline cancer immunotherapy company raised million private funding million ipo january juno therapeutics acquired biotechnology company celgene november bristolmyers squibb bms announced completed acquisition december company signed agreement opus bio inc chimeric antigen receptor cart cell product candidate targeting april company entered collaboration medimmune subsidiary astrazeneca investigating combination treatments cancer trials assess combinations one junos directed chimeric antigen receptor cell may company announced intention acquire stage cell therapeutics later month company launched collaboration editas medicine create cart highaffinity cell receptor therapies treat cancer potential generate millionplus june company acquired xbody june company announced partnership celgene valued part deal celgene pay juno million acquire million new juno shares valued existing juno shares rose celgene gain right sell junos therapies around world partnership surpasses previous highest record pfizer agreed deal merck kgaa january juno announced acquired abvitro allowing use nextgeneration single cell sequencing platforms complement ability create cells engineered target broad array cancer later july year company announced would acquire redoxtherapies acquisition provides juno exclusive license vipadenant small molecule adenosine receptor antagonist potential disrupt important immunosuppressive pathways tumor microenvironment certain cancers august company announced would license rights memorial sloan kettering cancer center eureka therapeutics novel fully human binding domain targeting bcell maturation january celgene announced would acquire juno abvitroacq redoxtherapiesacq httpsenwikipediaorgwikijunotherapeutics